Nationwide outbreak of red eye syndrome associated with transfusion of leukocyte-reduced red blood cell units

Infection Control and Hospital Epidemiology

Volumn 27, Issue 11, 2006, Pages 1146-1152

  Alonso Echanove, Juan ^a,f   Sippy, Brian D ^h   Chin, Arthur E ^a,b   Cairns, Lisa ^a,c,g   Haley, Rebecca ^d,i   Epstein, Jay S ^e   Richards, Michael J ^a,j   Edelhauser, Henry ^a   Hedberg, Katrina ^b   Kuehnert, Matthew J ^a   Jarvis, William R ^a   Pearson, Michele L ^a,l   Kobayashi, John ^c   Grossniklaus, Hans ^a   Veprek, Pavel ^a   Holley, Glen ^a   Pohl, Jan ^a   Lundstrom, Tammy ^k  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Office of Disease Prevention and Epidemiology   (United States)

^c WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

^d AMERICAN RED CROSS   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f Aveta Inc   (United States)

^g CENTERS FOR DIS CONTR AND PREV   (United States)

^h Montana Neuroscience Institute Foundation   (United States)

ⁱ Aldagen   (United States)

^j ROYAL MELBOURNE HOSPITAL   (Australia)

^k HARPER UNIVERSITY HOSPITAL   (United States)

^l NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE ACETATE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COHORT ANALYSIS; CONJUNCTIVAL ERYTHEMA; CONTROLLED STUDY; ERYTHEMA; ERYTHROCYTE COUNT; EYE DISEASE; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR HEMORRHAGE; LEUKOCYTE TRANSFUSION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHOTOPHOBIA; RABBIT; RED EYE SYNDROME; VISUAL ACUITY; VISUAL DISORDER;

ANIMALS; CONJUNCTIVA; DISEASE OUTBREAKS; ERYTHEMA; ERYTHROCYTE TRANSFUSION; EYE DISEASES; FILTRATION; HEMORRHAGE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MICHIGAN; OREGON; PAIN; PHOTOPHOBIA; RABBITS; SYNDROME; VISUAL ACUITY; WASHINGTON;

EID: 33751322192     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/508817     Document Type: Article

References (22)

1. Sloop GD, Friedberg RC. Complications of blood transfusion: how to recognize and respond to noninfectious reactions. Postgrad Med 1995; 98:159-162, 166, 169-172.
2. Wallace EL, Surgenor DM, Hao HS, et al. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993; 33:139-44.
3. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States. 1994. Transfusion 1998; 38:625-36.
4. Sullivan MT, Wallace EL. Blood collection and transfusion in the United States in 1999. Transfusion 2003; 43:141-148.
5. Schned AR, Silver H. The use of microaggregate nitration in the prevention of febrile transfusion reactions. Transfusion 1981; 21:675-681.
6. Lieden G, Hilden JO. Febrile transfusion reactions reduced by use of buffycoat-poor erythrocyte concentrates. Vox Sanguinis 1982; 43:263-263.
7. Mintz PD. Febrile reactions to platelet transfusions. Am J Clin Pathol 1991; 95:609-612.
8. Sirchia G, Wenz B, Rebulla P, et al. Removal of white cells from red cells by transfusion through a new filter. Transfusion 1990; 30:30-33.
9. Sirchia G, Rebulla P, Parravicini A, et al. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter. Transfusion 1987; 27:402-405.
10. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86:3598-3603.
11. Luban NL, Williams AE, MacDonald MG, Mikesell GT, Williams KM, Sacher RA. Low incidence of acquired cytomegalovirus infection in neonates transfused with washed red blood cells. Am J Dis Children 1987; 141:416-419.
12. Bowden RA. Cytomegalovirus infections in transplant patients: methods of prevention of primary cytomegalovirus. Transplant Proc 1991; 23(Suppl 3):136-138.
13. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997; 337:1861-1870.
14. Hebert PC, Hergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusion. JAMA 2003; 289:1941-1949.
15. Fergusson D, Herbert PC, Lee SK, et al. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants. JAMA 2003; 289:1950-1956.
16. US Food and Drug Administration (FDA). Update on: Leukocyte Reduction of Blood and Blood Components Public Workshop. Rockville, MD: FDA; 2005. Available at: http://www.fda.gov/cber/minutes/leuko072005t.htm#6. Accessed October 3, 2006.
17. Hutter JC, Kuchnert MJ, Wallis RR, Lucas AD, Sen S, Jarvis WR. Acute onset of decreased vision and hearing traced to hemodialysis treatment with aged dialyzers. JAMA 2000; 283:2128-2134.
18. Oba T, Tsuji K, Nakamura A, et al. Migration of acetylated hemicellulose from capillary hemodialyzer to blood, causing sclentis and/or iritis. Artif Organs 1984; 8:429-435.
19. Averhukh Z, Modai D, Sandbank J, et al. Red eye syndrome: clinical and experimental experience in a new aspect of diffuse ecosinophilic infiltration? Artif Organs 2001; 25:437-440.
20. Hutter JC, Long MC, Luu HM, Schroeder LW. Prediction of the shelf life of cellulose acetate hemodialyzers by Monte Carlo simulation. ASAIO Journal 2001; 47:522-527.
21. Ziegler M, Schlosser M, Abel P, Ziegler B. Antibody response in rats against non-toxic glucose sensor membranes tested in cell culture. Biomaterials 1994; 15:859-864.
22. Schlosser M, Ziegler B, Abel P, Fischer U, Ziegler M. Implantation of non-toxic material from glucose sensors: evidence for specific antibodies detected by ELISA. Horm Metabol Res 1994; 26:534-537.